MEMANTINA 20 mg Film-Coated Tablets
How to use MEMANTINE MABO 20 mg FILM-COATED TABLETS
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the User
Memantina MABO 20 mg Film-Coated Tablets EFG
Memantine Hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the Package Leaflet
- What is Memantina MABO and what is it used for.
- What you need to know before you take Memantina MABO.
- How to take Memantina MABO.
- Possible side effects.
- Storage of Memantina MABO.
- Contents of the pack and further information.
1. What is Memantina MABO and what is it used for
How Memantina MABO Works
Memantina MABO belongs to a group of medicines called anti-dementia medicines.
Memory loss in Alzheimer's disease is due to an alteration in brain signals. The brain contains so-called N-methyl-D-aspartate (NMDA) receptors that are involved in the transmission of important nerve signals in learning and memory.
Memantina MABO belongs to the group of medicines called NMDA receptor antagonists. Memantina MABO acts on these receptors, improving the transmission of nerve signals and memory.
What Memantina MABO is Used For
Memantina MABO is used in the treatment of patients with moderate to severe Alzheimer's disease.
2. What you Need to Know Before You Take Memantina MABO
Do Not Take Memantina MABO
- if you are allergic to the active substance memantine hydrochloride or to any of the other ingredients of this medicine (listed in section 6).
Warnings and Precautions
Consult your doctor or pharmacist before taking Memantina MABO:
- if you have a history of epileptic seizures (convulsions),
- if you have recently suffered a myocardial infarction (heart attack), if you have congestive heart failure or if you have uncontrolled hypertension (high blood pressure).
In these situations, treatment should be carefully supervised and your doctor should regularly reassess the clinical benefit of Memantina MABO.
If you have kidney problems, your doctor should closely monitor your kidney function and, if necessary, adjust the dose of memantine.
The use of memantine with other medicines such as amantadine (for the treatment of Parkinson's disease), ketamine (a medicine generally used to produce anesthesia), dextromethorphan (a medicine for the treatment of cough) and other NMDA antagonists should be avoided.
Children and Adolescents
The use of Memantina MABO is not recommended in children and adolescents under 18 years of age.
Taking Memantina MABO with Other Medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
In particular, the administration of Memantina MABO may produce changes in the effects of the following medicines, so your doctor may need to adjust the dose:
- amantadine, ketamine, dextromethorphan,
- dantrolene, baclofen,
- cimetidine, ranitidine, procainamide, quinidine, quinine, nicotinamide,
- hydrochlorothiazide (or any combination with hydrochlorothiazide),
- anticholinergics (substances generally used to treat movement disorders or intestinal spasms),
- anticonvulsants (substances used to prevent and eliminate convulsions),
- barbiturates (substances generally used to induce sleep),
- dopaminergic agonists (substances such as L-dopa, bromocriptine),
- neuroleptics (substances used in the treatment of mental illnesses),
- oral anticoagulants.
If you are hospitalized, inform your doctor that you are taking Memantina MABO.
Taking Memantina MABO with Food, Drinks, and Alcohol
You should inform your doctor if you have recently changed or intend to change your diet substantially (e.g., from a normal diet to a strict vegetarian diet) or if you have renal tubular acidosis (RTA, excess of acid-producing substances in the blood due to kidney dysfunction) or severe urinary tract infections (urinary tract), as your doctor may need to adjust the dose of the medicine.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
The use of memantine is not recommended in pregnant women.
Breastfeeding
Women taking Memantina MABO should stop breastfeeding.
Driving and Using Machines
Your doctor will inform you if your illness allows you to drive and use machines safely. Also, Memantina MABO may affect your reaction ability, so driving or operating machinery may be inappropriate.
Memantina MABO Contains Sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
3. How to Take Memantina MABO
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
Posology
The recommended dose of memantine for adults and elderly patients is 20 mg administered once a day.
To reduce the risk of adverse effects, this dose should be achieved gradually following a daily treatment scheme. To adjust the dose, there are tablets with different doses.
At the start of treatment, you will begin taking half a tablet of Memantina MABO 10 mg film-coated tablets once a day. This dose will be increased weekly by 5 mg until the recommended maintenance dose is reached (20 mg once a day), which is achieved at the beginning of the fourth week.
Posology for Patients with Renal Impairment
If you have kidney problems, your doctor will decide the appropriate dose for your condition. In this case, your doctor should periodically monitor your kidney function.
Administration
Memantina MABO should be administered orally once a day. To get the most out of your medication, you should take it every day and at the same time. The tablets should be swallowed with a little water. The tablets can be taken with or without food.
Duration of Treatment
Continue taking Memantina MABO as long as it is beneficial for you. Your doctor should periodically evaluate the effects of your treatment.
If You Take More Memantina MABO Than You Should
Generally, taking an excessive amount of Memantina MABO should not cause you any harm. You may experience an increase in the symptoms described in section 4 "Possible side effects".
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If You Forget to Take Memantina MABO
If you realize you have forgotten to take your dose of Memantina MABO, wait and take the next dose at the usual time.
Do not take a double dose to make up for the forgotten dose.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible Side Effects
Like all medicines, Memantina MABO can cause side effects, although not everybody gets them.
Generally, side effects are mild to moderate.
Frequent (may affect up to 1 in 10 people):
- Headache, drowsiness, constipation, elevated liver function tests, dizziness, balance disorder, shortness of breath, high blood pressure, and hypersensitivity to the medicine.
Uncommon (may affect up to 1 in 100 people):
- Fatigue, fungal infections, confusion, hallucinations, vomiting, gait disturbance, heart failure, and venous thrombosis/thromboembolism.
Rare (may affect up to 1 in 1,000 people):
- Seizures
Frequency Not Known (frequency cannot be estimated from the available data):
- Pancreatitis, hepatitis (inflammation of the liver), and psychotic reactions.
Alzheimer's disease has been associated with depression, suicidal ideation, and suicide. These events have been reported in patients treated with Memantina MABO.
Reporting of Side Effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) via their website: www.notificaram.es
By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Memantina MABO
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month shown.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
6. Contents of the Pack and Further Information
Composition of Memantina MABO
- The active substance is memantine hydrochloride. Each film-coated tablet contains 20 mg of memantine hydrochloride, equivalent to 16.62 mg of memantine.
- The other ingredients are: Core: microcrystalline cellulose, sodium croscarmellose, anhydrous colloidal silica, magnesium stearate; Coating: polyvinyl alcohol, macrogol 3350, talc, titanium dioxide (E-171), yellow iron oxide (E-172), and red iron oxide (E-172).
Appearance of the Product and Contents of the Pack
Memantina MABO 20 mg film-coated tablets are pale red, oval-shaped with a break line on one side.
Memantina MABO film-coated tablets are presented in PVC-PVDC/Aluminum blisters in packs of 56 tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder
MABO-FARMA S.A.
Calle Vía de los Poblados 3,
Edificio 6, 28033, Madrid,
Spain.
Manufacturer
NOUCOR HEALTH, S.A.
Avda. Camí Reial, 51-57
08184 Palau-solità i Plegamans
Barcelona, Spain
Date of Last Revision of this Leaflet:March 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/
- Country of registration
- Dosage formTABLET, 20 mg
- ATC codeN06DX01
- Active substance
- Prescription requiredYes
- Manufacturer
- CompositionCROSCARMELOSA SODICA (9,00 mg mg)
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to MEMANTINE MABO 20 mg FILM-COATED TABLETSDosage form: TABLET, 10 mgActive substance: memantineManufacturer: Merz Pharmaceuticals GmbhPrescription requiredDosage form: TABLET, 10 mgActive substance: memantineManufacturer: Merz Pharmaceuticals GmbhPrescription requiredDosage form: TABLET, 20 mgActive substance: memantineManufacturer: Merz Pharmaceuticals GmbhPrescription required
Online doctors for MEMANTINE MABO 20 mg FILM-COATED TABLETS
Discuss questions about MEMANTINE MABO 20 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Book a video appointment 
Book a video appointment 
Book a video appointment 
Book a video appointment 
Book a video appointment 
Book a video appointment 
Book a video appointment 
Book a video appointment 
Book a video appointment 
Get MEMANTINE MABO 20 mg FILM-COATED TABLETS Prescription Online
Fill in a 2-min form
Tell us your symptoms, history, and what medicine you're requesting.
Pick a doctor or let us assign
Choose a specialist or we'll match you with the next available doctor.
Doctor reviews your case
Usually within 30 minutes. They may ask follow-up questions via chat.
Collect from any pharmacy
Electronic prescription sent to your email — valid across Spain.
Frequently Asked Questions
Is a prescription required for MEMANTINE MABO 20 mg FILM-COATED TABLETS?
MEMANTINE MABO 20 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MEMANTINE MABO 20 mg FILM-COATED TABLETS?
The active ingredient in MEMANTINE MABO 20 mg FILM-COATED TABLETS is memantine. This information helps identify medicines with the same composition but different brand names.
Who manufactures MEMANTINE MABO 20 mg FILM-COATED TABLETS?
MEMANTINE MABO 20 mg FILM-COATED TABLETS is manufactured by Mabo Farma S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MEMANTINE MABO 20 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MEMANTINE MABO 20 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
How to buy MEMANTINE MABO 20 mg FILM-COATED TABLETS in Spain?
Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.
You can buy MEMANTINE MABO 20 mg FILM-COATED TABLETS in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.
To obtain a prescription, you can use Oladoctor:
What are the alternatives to MEMANTINE MABO 20 mg FILM-COATED TABLETS?
Other medicines with the same active substance (memantine) include AXURA 10 mg FILM-COATED TABLETS, AXURA 10 mg FILM-COATED TABLETS, AXURA 20 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
